Celgene, the biopharma firm specialising in cancer and inflammatory diseases, has elected Richard Barker to its board of directors. Dr …
Aegate’s board of directors have announced that the previous director general of the ABPI has joined the company as a …
Ever since Aneurin Bevan launched Britain’s fledgling health service in 1948, the UK-based pharmaceutical industry and the NHS have stood …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

